Geritom Medical

Pharmaceuticals

United States, Minnesota

$25M to $50M

51-200

H3 Biomedicine

Pharmaceuticals

United States, Massachusetts

$25M to $50M

51-200

Therapeutics

Pharmaceuticals

United States, California

$25M to $50M

51-200

Hanford Pharmaceuticals

Pharmaceuticals

United States, New York

$25M to $50M

51-200

Allegiant Health

Pharmaceuticals

United States, New York

$25M to $50M

51-200

US Pharmaceutical Corporation

Pharmaceuticals

United States, Georgia

$25M to $50M

51-200

Diaceutics

Pharmaceuticals

United States, New Jersey

$25M to $50M

51-200

Coating Place

Pharmaceuticals

United States, Wisconsin

$25M to $50M

51-200

Imaging Endpoints

Pharmaceuticals

United States, Arizona

$25M to $50M

51-200

Symbio Proinnovera

Pharmaceuticals

United States, New York

$25M to $50M

51-200

RxSafe

Pharmaceuticals

United States, California

$25M to $50M

51-200

Hill Dermaceuticals

Pharmaceuticals

United States, Florida

$25M to $50M

51-200

BioScience Communications

Pharmaceuticals

United States, New York

$25M to $50M

51-200

ARx

Pharmaceuticals

United States, Pennsylvania

$25M to $50M

51-200

Community Care Rx

Pharmaceuticals

United States, New York

$25M to $50M

51-200

Carepoint Pharmacy

Pharmaceuticals

United States, Illinois

$25M to $50M

51-200

ApiJect Systems

Pharmaceuticals

United States, Connecticut

$25M to $50M

51-200

Pharmacy Advantage Specialty Pharmacy

Pharmaceuticals

United States, Michigan

$25M to $50M

51-200

SSCI, a Division of AMRI

Pharmaceuticals

United States, Indiana

$25M to $50M

51-200

Innocoll Biotherapeutics

Pharmaceuticals

United States, New Jersey

$25M to $50M

51-200